In addition, we investigated the expression profile of TP53INP1 which is highly homologous to TP53INP2, whereas the result showed no significant difference between NPM1-mutated and NPM1-unmutated AML patients. This evidence concerns the gene TP53INP2 and acute myeloid leukemia.